Abstract
The combination strategy of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables successful and enhanced rAAV multi-administration to liver
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have